> 1) Even with resistance on the rise, we still have antibiotics that work. Phage therapy is a "someday we're going to need this...we think" type treatment.
We have antibiotics that work for most infections. For people with antibiotic-resistant infections (especially hospital-borne ones) they are already not an option. A childhood acquaintance of mine with CF recently died of an antibiotic-resistant infection in her newly-transplanted lungs. Lack of awareness and research into phage therapy was fatal in her case, as it meant they started the process late and it took longer than it needed to.
Said process is: take samples of the infectious agent, culture them, and send the cultured bacteria to "phage banks" so they can test their existing phages against it. There's a lead time both because of the initial setup required per-patient, and because of the scarcity of comprehensive phage banks and the lack of good coordination between them.
I'm not aware of any phage treatments suitable for lung infections - mostly, it's been skin and soft tissue sites, but I'd be happy to know if there is one.
And yes, highly resistant infections are a problem - and one I work on - but from a "market forces" perspective they're still relatively rare. Even for most highly resistant infections we still have some antibiotics that work - not well, and not without side effects, etc.
Not any current standard phage mixtures, but especially for lung disease they're an active area of research. Delivery mechanisms seem to be a pretty solved/relatively-trivial problem. See e.g. https://www.sciencedirect.com/science/article/pii/S156919931...
In this particular case, they found a phage for the particular infection, but at too late of a stage - most of the development I've heard of has been less about basic research and more about building institutional processes for quickly finding existing predators of a given bacterium. (Which, I agree, is a lot more expensive and risky than an antibiotic if you can find one that works.)
We have antibiotics that work for most infections. For people with antibiotic-resistant infections (especially hospital-borne ones) they are already not an option. A childhood acquaintance of mine with CF recently died of an antibiotic-resistant infection in her newly-transplanted lungs. Lack of awareness and research into phage therapy was fatal in her case, as it meant they started the process late and it took longer than it needed to.
Said process is: take samples of the infectious agent, culture them, and send the cultured bacteria to "phage banks" so they can test their existing phages against it. There's a lead time both because of the initial setup required per-patient, and because of the scarcity of comprehensive phage banks and the lack of good coordination between them.